AstraZeneca Pharma India surrenders marketing authorisation for Olaparib 100mg and 150mg
The discontinuation decision is only on the basis of commercial reasons and is not due to efficacy or safety reasons
The discontinuation decision is only on the basis of commercial reasons and is not due to efficacy or safety reasons
The Atlan A100 system delivers advanced ventilation technology for adults, pediatric patients, and neonates, revolutionizing care with seamless workflows across hospital departments
Strengthening capabilities in Peptide Therapeutics and CDMO services
The board of directors accepted Hrosz’s resignation and expressed appreciation for his significant contributions during his tenure
NATCO has decided to price the product at Rs.15, 900 MRP consistent with the company’s stand before the court
Pregabalin Gel 8% is a novel topical solution for diabetic neuropathic pain
Fexuprazan has the longest half-life of 9 hours among potassium-competitive acid blockers
This investment is in addition to its first multi-billion-dollar project that was awarded to Fluor in 202
The Peptide Research Center is designed to support innovator pharma and biotech companies with specialized services across peptide synthesis, discovery, and advanced modalities, including complex conjugates
PRX-PLUS has a unique product feature with its deep-impacting formula
Subscribe To Our Newsletter & Stay Updated